Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Other Non-Current Assets (2018 - 2026)

Alector's (ALEC) quarterly Other Non-Current Assets came in at $1.8 million in Q2 2026, little changed year-over-year from $1.8 million in Q2 2025, and little changed quarter-over-quarter from $1.8 million in Q1 2026.

Analysis

Alector (ALEC) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Other Non-Current Assets for 9 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.8 million, down 59.38% from the prior year.
  • Other Non-Current Assets was $1.8 million for Q2 2026 at Alector, roughly flat from $1.8 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $7.4 million in Q4 2023 and troughed at $1.5 million in Q1 2022.
  • A 5-year average of $2.5 million and a median of $1.7 million in 2023 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 189.2% in 2025, down 59.38% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $6.4 million in 2022, then increased by 15.74% to $7.4 million in 2023, then plunged by 38.74% to $4.5 million in 2024, then plunged by 59.38% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.8 million (Q2 2026), $1.8 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 124.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 65.13 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 831.80 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 104.44 Mn
10 Alector 274.68 Mn 101.88 Mn - 1.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.85 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.85 Mn
Sep 30, 2025 4.47 Mn
Jun 30, 2025 1.85 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 4.54 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 1.55 Mn
Dec 31, 2023 7.42 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 6.41 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 1.47 Mn
Mar 31, 2022 1.47 Mn
Dec 31, 2021 5.57 Mn
Sep 30, 2021 1.47 Mn